{"id":"W2024076573","doi":"10.1016/j.jconrel.2015.02.001","title":"Polypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models","year":2015,"lang":"en","type":"article","venue":"Journal of Controlled Release","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"National Institute of General Medical Sciences; National Cancer Institute; National Institutes of Health; Nebraska Department of Health and Human Services; Foundation for the National Institutes of Health; U.S. Department of Defense","keywords":"Doxorubicin; Nanocarriers; In vivo; Breast cancer; Trastuzumab; Chemistry; Pharmacology; Cytotoxicity; Cancer research; Drug delivery; Chemotherapy; Drug; Cancer; In vitro; Medicine; Biology; Internal medicine; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001690478,0.0002891138,0.001550277,0.0006851091,0.00005806967,0.0000385699,0.0002252521,0.0001211431,0.00007528161],"category_scores_gemma":[0.0006069473,0.0002023331,0.0002674373,0.0005278506,0.0001732063,0.0003099246,0.00002796241,0.0008202529,0.000002634598],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009556929,"about_ca_system_score_gemma":0.003630157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008882549,"about_ca_topic_score_gemma":0.0001247397,"domain_scores_codex":[0.9960235,0.0004619142,0.00105363,0.0002658915,0.001711827,0.0004832706],"domain_scores_gemma":[0.995872,0.0003669453,0.00120119,0.0003325356,0.001634236,0.000593094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.09468913,0.00415288,0.07647461,0.0007726284,0.0009646188,0.003480544,0.0006830734,0.4373809,0.3690623,0.0001786042,0.00194981,0.01021093],"study_design_scores_gemma":[0.1690785,0.004427031,0.03660643,0.005732717,0.0008101598,0.0007155885,0.0005413472,0.7558055,0.02541116,0.0002787305,0.00007087248,0.0005219684],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902947,0.0006157332,0.003756193,0.003316295,0.0001347664,0.001126599,0.00005680336,0.00001612281,0.0006827852],"genre_scores_gemma":[0.9987916,0.00005347255,0.0004538389,0.0002325094,0.0001910432,0.00004624402,0.000004046999,0.00004989698,0.0001773194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3436511,"threshold_uncertainty_score":0.8250906,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03961456749424253,"score_gpt":0.3328177206858932,"score_spread":0.2932031531916506,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}